FISHER & PAYKEL HEALTHCARE TO ANNOUNCE HALF YEAR RESULTS ON 11 NOVEMBER 2003
Fisher & Paykel Healthcare Corporation Limited (NZX:FPH. ASX:FPH) announced today that it intends to release on Tuesday 11 November its results for the six months ended 30 September 2003.
The release will be issued shortly after 8.30am NZT, 6.30am AEST (2.30pm, Monday 10
November 2003 USEST). Fisher & Paykel Healthcare will host a conference call to review the results and to discuss the outlook for the remainder of the 2004 financial year. The conference call will be broadcast simultaneously over the Internet.
To listen to the webcast, to be held at 9.30am NZT, 7.30am AEST on Tuesday 11 November (3.30pm USEST, Monday 10 November 2003), access the company’s website at www.fphcare.com. Please allow extra time prior to the webcast to visit the site and download the streaming media software required. An online archive of the event will be available approximately two hours after the webcast and will remain onsite for approximately two weeks.
For those people unable to access the call via the Internet, we are making available an audio replay of the conference call. This will be available on the day of the release from approximately 11.30am NZT for two weeks. To listen to the replay dial +61 2 8524 1009 international or 02 8524 1009 within Australia. The passcode to access the recording is 124996#.
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of heated humidification products and systems for use in respiratory care and the treatment of obstructive sleep apnea. It also offers an innovative range of patient warming devices and neonatal care products. The company’s products are sold in over 90 countries worldwide.
Further information can be obtained by contacting Michael Daniell on +64 9 574 0161 or Tony Barclay on +64 9 574 0119 at Fisher & Paykel Healthcare Corporation Limited or by visiting the company’s website at www.fphcare.com
Fisher & Paykel Healthcare to announce half year results
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment